Sight Sciences (SGHT) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SGHT shares.
View SGHT analyst ratings or view top-rated stocks.

7 Wall Street research analysts have issued 1 year target prices for Sight Sciences' stock. Their SGHT share price forecasts range from $15.00 to $15.00. On average, they expect the company's stock price to reach $15.00 in the next twelve months. This suggests a possible upside of 99.5% from the stock's current price.
View analysts price targets for SGHT or view top-rated stocks among Wall Street analysts.

Sight Sciences' stock was trading at $12.21 at the beginning of the year. Since then, SGHT stock has decreased by 38.4% and is now trading at $7.52.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our SGHT earnings forecast.

Sight Sciences, Inc. (NASDAQ:SGHT) posted its quarterly earnings data on Monday, March, 13th. The company reported ($0.35) earnings per share for the quarter, topping analysts' consensus estimates of ($0.42) by $0.07. The firm earned $20.54 million during the quarter, compared to the consensus estimate of $20.38 million. Sight Sciences had a negative net margin of 106.34% and a negative trailing twelve-month return on equity of 47.71%. During the same quarter in the previous year, the company posted ($0.34) earnings per share.

ETFs with the largest weight of Sight Sciences (NASDAQ:SGHT) stock in their portfolio include Global X Aging Population ETF (AGNG), Principal Healthcare Innovators ETF (BTEC),

Sight Sciences updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $89.00 million-$94.00 million, compared to the consensus revenue estimate of $91.64 million.

(SGHT) raised $150 million in an IPO on Thursday, July 15th 2021. The company issued 6,980,000 shares at $20.00-$23.00 per share.

Sight Sciences trades on the NASDAQ under the ticker symbol "SGHT."

Sight Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include KCK LTD. (9.73%), BlackRock Inc. (3.50%), Jackson Square Partners LLC (2.64%), ArrowMark Colorado Holdings LLC (2.41%), Russell Investments Group Ltd. (2.04%) and Apollo Management Holdings L.P. (1.39%). Insiders that own company stock include Jesse Selnick and Staffan Encrantz.
View institutional ownership trends.

Shares of SGHT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SGHT stock can currently be purchased for approximately $7.52.

Sight Sciences (NASDAQ:SGHT) has a market capitalization of $364.42 million and generates $71.33 million in revenue each year. The company earns $-86,240,000.00 in net income (profit) each year or ($1.66) on an earnings per share basis.

The company employs 212 workers across the globe.

Sight Sciences' mailing address is 4040 CAMPBELL AVE SUITE 100, MENLO PARK CA, 94025. The official website for the company is www.sightsciences.com. The company can be reached via phone at 877-266-1144 or via email at investor.relations@sightsciences.com.